Clinical Trial Update: Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a combination of Botensilimab and Balstilimab with a fasting-mimicking diet plus Vitamin C in KRAS-mutant metastatic colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)

Snippet

Sponsor: University of Southern California | Conditions: Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 1 | Status: RECRUITING